379
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Phenotypic Detection of Carbapenem-Resistant Gram-Negative Bacilli from a Clinical Specimen in Sidama, Ethiopia: A Cross-Sectional Study

ORCID Icon, ORCID Icon, , , , , , & show all
Pages 369-380 | Published online: 02 Feb 2021

References

  • WHO. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. 2017.
  • Codjoe FS, Eric S. Carbapenem resistance: a review. Med Sci. 2018;6(1):1. doi:10.3390/medsci6010001
  • Hu FCS, Xu X, Guo Y, Liu Y, Zhu D, Zhang Y. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China. J Med Microbiol. 2012;61(1):132–136. doi:10.1099/jmm.0.036483-021903823
  • Meletis G. Carbapenem resistance: an overview of the problem and future perspectives. Therap Adv Infect Dis. 2016;3(1):15–21. doi:10.1177/204993611562170926862399
  • CaLSI C. Performance Standards for Antimicrobial Susceptibility Testing. West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA: Clinical and Laboratory Standards Institute; 2019:950.
  • Testing E Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0; 2019 Available from: http://wwweucastorg. Accessed 113, 2020
  • Bonomo RA, Burd EM, Conly J, et al. Carbapenemase-producing organisms: a global scourge. Clin Infect Dis. 2018;66(8):1290–1297. doi:10.1093/cid/cix89329165604
  • Gniadek TJ, Carroll KC, Simner PJ, Kraft CS. Carbapenem-resistant non-glucose-fermenting gram-negative bacilli: the missing piece to the puzzle. J Clin Microbiol. 2016;54(7):1700–1710. doi:10.1128/JCM.03264-1526912753
  • Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012;18(9):1503–1507. doi:10.3201/eid1809.12035522932472
  • Nordmann P, Poirel L. Strategies for identification of carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2013;68(3):487–489. doi:10.1093/jac/dks42623104494
  • Pierce VM, Simner PJ, Lonsway DR, et al. Modified carbapenem inactivation method for phenotypic detection of carbapenemase production among Enterobacteriaceae. J Clin Microbiol. 2017;55(8):2321–2333. doi:10.1128/JCM.00193-1728381609
  • LJaL B. The problem of carbapenemase-producing carbapenem-resistant Enterobacteriaceae detection. J Clin Microbiol. 2016;JCM. 02771–02715.
  • Gupta NLB, Patel J, Kallen A, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53(1):60–67. doi:10.1093/cid/cir20221653305
  • Ling MTY, Tan S, Amin I, How K, Tan K, Lee L. Risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in an acute tertiary care hospital in Singapore. Antimicrob Resist Infect Control. 2015;4:26. doi:10.1186/s13756-015-0066-326106476
  • Kalam KQF, Baqi S, Baqi S, Baqi S, Baqi S. Risk factors for carbapenem-resistant bacteraemia and mortality due to gram-negative bacteraemia in a developing country. J Pak Med Assoc. 2014;64(5):530–536.25272538
  • Meiling L, Wang J, Tan R, et al. Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae: a 4-year quasi-experimental before-and-after study. Antimicrob Resist Infect Control. 2019;8(8).
  • David Aguilera-Alonso LEG, Saavedra-Lozano J, Cercenado E, Fernando BA. Carbapenem-resistant gram-negative infections in children. Antimicrob Agents Chemother. 2019.
  • Johanna M, Vanegas OLP, Jiménez JN. Molecular epidemiology of carbapenem-resistant gram-negative bacilli from an infected pediatric population in tertiary-care hospitals in Medellín, Colombia: an increasing problem. BMC Infect Dis. 2016;16:463. doi:10.1186/s12879-016-1805-727585707
  • Nulens E, Gonzalo Bearman M, Fshea F. Guide to infection control in the hospital. Int Soc Infect Dis. 2018;1–16.
  • David O, Ogbolu LJVP, Mark AW. Opening Pandora’s box: high-level resistance to antibiotics of last resort in Gram 1 negative bacteria from Nigeria. bioRxiv. 2018. doi:10.1101/344093
  • Deogratius Okoche BBA, Katabazi FA, Kato L, Najjuka CF, Najjuka CF. Prevalence and characterization of carbapenem-resistant enterobacteriaceae isolated from Mulago National Referral Hospital, Uganda. PLoS One. 2015;10(8):e0135745. doi:10.1371/journal.pone.013574526284519
  • Igwe OA, Amauche Igwe H. Carbapenem-resistant Enterobacteriaceae (CRE) and gram-negative bacterial infections in south-west Nigeria: a retrospective epidemiological surveillance study</em>. AIMS Public Health. 2020;7(4):804–815.33294483
  • Nada AB, Hisham AN, Kamal ME. Molecular characterization of carbapenem-resistant gram-negative bacteria in Khartoum (Sudan). Afr J Med Sci. 2020;5(2).
  • Setegn Eshetie CU, Gelaw A, Ayelign B, Endris M, Moges F. Multidrug-resistant and carbapenemase-producing Enterobacteriaceae among patients with urinary tract infection at referral Hospital, Northwest Ethiopia. Antimicrob Resist Infect Control. 2015;4(12).
  • Beyene DBA, Fantew S, Mihret A, Evans M, Evans M. Multidrug-resistant profile and prevalence of extended-spectrum β-lactamase and carbapenemase production in fermentative Gramnegative bacilli recovered from patients and specimens referred to National Reference Laboratory, Addis Ababa, Ethiopia. PLoS One. 2019;14(9):e0222911. doi:10.1371/journal.pone.022291131553773
  • Mitiku M, Ayenew Z, Desta K. Multi-drug resistant, extended spectrum beta-lactamase and carbapenemase producing bacterial isolate among septicemia suspected under five children in Tikur Anbesa Specialized Hospital, Addis Ababa Ethiopia: cross-sectional study. 2019.
  • Gashaw M, Berhane M, Bekele S, et al. Emergence of high drug-resistant bacterial isolates from patients with healthcare-associated infections at Jimma University medical centre: a cross-sectional study. Antimicrob Resist Infect Control. 2018;7(1):138.30479751
  • Magiorakos APSA, Carey RB, Carmeli Y, Falagas ME, Giske CG. Multidrug-resistant, extensively drug-resistant and pan drug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
  • Fenollar F, Mediannikov O. Emerging infectious diseases in Africa in the 21st century. N Microbes N Infect. 2018;26:S10–S18. doi:10.1016/j.nmni.2018.09.004
  • Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229–241. doi:10.1177/204209861455491925436105
  • Aliyu S. Carbapenemase-producing Gram-negative bacteria: an emerging threat to health care in Africa. Ann Niger Med. 2013;7(1):1. doi:10.4103/0331-3131.119978
  • Kaur MGS, Kaur T. Detection of carbapenem-resistant gram-negative bacteria in clinical isolates from a tertiary care hospital. J Bacteriol Mycol Open Access. 2016;2(1):00011.
  • Devi P. Incidence of carbapenem-resistant nonfermenting gram-negative bacilli from patients with respiratory tract infections among intensive care units. Int J Res Med Sci. 2017;3(6):4.
  • Mate PDK, Devi K, Damrolien S, Devi P. Prevalence of carbapenem resistance among Gram-negative bacteria in a tertiary care hospital in north-east India. IOSR J Dent Med Sci. 2014;13(12):56–60. doi:10.9790/0853-131235660
  • Tadesse MZ, Kassu D. Multi-drug resistant, extended-spectrum beta-lactamase and carbapenemase-producing bacterial isolates among children under five years old suspected bloodstream infection in a specialized Hospital in Ethiopia: cross-sectional study. 2019.
  • Gashaw MBM, Bekele S, Kibru G, et al. Emergence of high drug-resistant bacterial isolates from patients with healthcare-associated infections at Jimma University medical centre: a cross-sectional study. Antimicrob Resist Infect Control. 2018;7:138.30479751
  • Codjoe FDE, Smith T, Miller K, Miller K. Phenotypic and genotypic characterization of carbapenem-resistant gram-negative bacilli pathogens from hospitals in Ghana. Microbial Drug Resist. 2019;25(10):1449–1457. doi:10.1089/mdr.2018.0278
  • Katchanov JAL, Klupp E, Both A, et al. Carbapenem-resistant Gram-negative pathogens in a German university medical centre: prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations. PLoS One. 2018;13(4):e0195757. doi:10.1371/journal.pone.019575729649276
  • Souli M, Galani I, Giamarellou H. Emergence of extensively drug-resistant and pan drug-resistant Gram-negative bacilli in Europe. Eurosurveillance. 2008;13(47):19045.19021957
  • Brink A, Coetzee J, Clay C, et al. The spread of carbapenem-resistant Enterobacteriaceae in South Africa: risk factors for acquisition and prevention. SAMJ. 2012;102(7):599–601. doi:10.7196/SAMJ.578922748433
  • Codjoe FS. Detection and Characterisation of Carbapenem-Resistant Gram-Negative Bacilli Infections in Ghana. Sheffield Hallam University; 2016.
  • Adesanya OA, Igwe HA. Carbapenem-resistant Enterobacteriaceae (CRE) and gram-negative bacterial infections in south-west Nigeria: a retrospective epidemiological surveillance study. AIMS Public Health. 2020;7(4):804.33294483
  • Kenneth SDK, Edward W, Francis E, Ejobi F. A systematic review: the current status of carbapenem resistance in East Africa. BMC Res Notes. 2018;11:629. doi:10.1186/s13104-018-3738-230170613
  • ASaN K Prevalence and susceptibility analysis of carbapenem-resistant gram-negative pathogens in Tertiary Care Hospital, Mumbai; 2020 Available from: https://wwwjbclinpharmorg. Accessed 113, 2020
  • Peterson L. Bad bugs, no drugs: no ESCAPE revisited. Clin Infect Dis. 2009;49:992–993. doi:10.1086/60553919694542
  • Souha SZA, Kanafani ZA. Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum β-lactamase–producing enterobacteriaceae, carbapenem-resistant enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin Proc. 2011;86(3):250–259. doi:10.4065/mcp.2010.067421364117
  • Feleke MSE, Wondwossen A, Feleke M, et al. High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Amhara region. PLoS One. 2019;14(4):1–13.
  • Bitew A. High prevalence of multi-drug resistance and extended spectrum beta-lactamase production in non-fermenting gram-negative bacilli in Ethiopia. Infect Dis. 2019;12:1–7.
  • Mohammedaman MAA, Tsegaye S, Kim H. Antimicrobial susceptibility pattern of bacterial isolates from wound infection and their sensitivity to alternative topical agents at Jimma University Specialized Hospital, South-West Ethiopia. Ann Clin Microbiol Antimicrob. 2014;13(14):3–10. doi:10.1186/1476-0711-13-324393579
  • Wondemagegn MBA, Mulat Y, Tadesse H, Haimanot A, Dereje A, Abate D. Bacterial agents and antibiotic resistance profiles of infections from different sites that occurred among patients at Debre Markos Referral Hospital, Ethiopia: a cross‑sectional study. BMC Res Notes. 2017;10:254. doi:10.1186/s13104-017-2584-y28683780
  • Mulugeta KBA. Bacteriology and antibiogram of pathogens from wound infections at Dessie Laboratory, North-East Ethiopia. Tanzan J Health Res. 2011;13(4).
  • Dejenie SAA, Melese H, Tesfaye L, Hiwot K, Kassu D. Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia. Antimicrob Resist Infect Control. 2019;8(39):3–12. doi:10.1186/s13756-018-0456-430627427
  • Derese HAD, Daniel M, Yohannes Z, Yesuf A, Seble W, Fantahun B. Drug resistance patterns of bacterial isolates from infected wounds at Bahir Dar Regional Health Research Laboratory Center, Northwest Ethiopia. Ethiop J Health Dev. 2016;30(3):113–117.
  • Silpi BPS, Monali R. Multidrug-resistant and extensively drug-resistant bacteria: a study. J Pathog. 2015;2016:5.
  • Abtie HT, Teshome B, Gebreselassie D, Mihiretie GD. The bacterial profile and antibiotic susceptibility pattern among patients with suspected bloodstream infections, Gondar, north-west Ethiopia. Pathol Labor Med Int. 2018;10:1–7. doi:10.2147/PLMI.S153444
  • Degefu AB, Surafel F, Amete M, Martin E. Multidrug-resistant profile and prevalence of extended-spectrum β-lactamase and carbapenemase production in fermentative Gram-negative bacilli recovered from patients and specimens referred to National Reference Laboratory, Addis Ababa, Ethiopia. PLoS One. 2019;14(9):1–13.
  • Tsegaye AMA, Enkosilassie M, Mengistu H. The burden of antimicrobial resistance at tertiary care hospital, southern Ethiopia: a three years’ retrospective study. BMC Infect Dis. 2019;20(585):1–8.31892320
  • Aynalem ME, Teklay G, Moges T, Feleke M. Bacterial isolates and their antimicrobial susceptibility patterns of wound infections among inpatients and outpatients attending the University of Gondar Referral Hospital, Northwest Ethiopia. Int J Microbiol. 2017;2017:10.